Respiratory News and Research

RSS

Study explores airborne bird flu decay in livestock environments

Discovering how the bird flu virus degrades in the air around livestock and how engineering solutions can effect that degradation quickly and efficiently are core aims of a new University of Michigan Engineering-led project funded by the U.S. Department of Agriculture.

27 Mar 2026

Aging lung cells drive severe inflammation in flu and COVID

Older adults are much more likely to become seriously ill from flu or COVID because aging lung cells can drive excessive immune responses, according to a new study led by researchers at UC San Francisco.

27 Mar 2026

Machine learning model can predict 28-day mortality in sepsis patients

Sepsis is one of the most common and lethal syndromes encountered in intensive care units (ICUs), and acute respiratory failure (ARF) represents one of its most critical complications.

27 Mar 2026

Do multi-strain probiotics improve long covid symptoms?

Multi-strain probiotics show potential to modulate gut microbiome in long COVID, yet their impact on inflammation and recovery is not statistically significant.

27 Mar 2026

50 years of data reveal higher death risks in London transport workers

A 50-year retrospective cohort study of 117,166 Transport for London workers found that bus and London Underground job categories had higher all-cause, respiratory, cardiovascular, and lung cancer mortality than office workers. The authors caution that broad job categories, missing cause-of-death data, and unmeasured confounding mean the findings show association, not proof of specific occupational causes.

26 Mar 2026

Experts establish standardized protocols for pediatric recurrent wheezing diagnosis

Recurrent wheezing, a respiratory disorder, is caused by the narrowing of the airways, mainly affecting children aged less than 5 years.

26 Mar 2026

CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater

CDC surveillance shows that the highly divergent SARS-CoV-2 variant BA.3.2 spread to at least 23 countries and was detected in U.S. travelers, patients, airplane wastewater, and wastewater samples across multiple states. The report highlights wastewater and traveler-based genomic surveillance as early warning tools while noting that BA.3.2 has immune-evasion potential but has not rapidly displaced other circulating lineages.

25 Mar 2026

Can camel milk improve health? Review highlights benefits but warns against drinking it raw

A narrative review in Food Science & Nutrition examined studies published from 2000 to 2025 and found that camel milk contains bioactive compounds with potential glycemic, anti-inflammatory, gut, and other health benefits. It also stressed that raw, unpasteurized camel milk poses microbial and zoonotic risks, underscoring that safety remains a key part of the story.

25 Mar 2026

No link between Covid-19 vaccines and sudden cardiac death

The study reveals COVID-19 vaccines do not increase sudden cardiac death risk in youth, highlighting the importance of accurate health messaging.

24 Mar 2026

New Legionella testing selective agar plates launched by AnalytiChem

AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has launched a new addition to its high-quality Redipor® microbiological prepared media portfolio.

From AnalytiChem 24 Mar 2026

Study revises the understanding of neutrophil dynamics during respiratory viral infection

Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these cells has been a subject of debate.

23 Mar 2026

Can your voice reveal stress levels?

This research explores speech prosody as a stress marker, analyzing the effects of relaxation methods on vocal changes and their implications for stress relief.

23 Mar 2026

Major UK clinical trial finds surfactant therapy ineffective for severe bronchiolitis

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis - a seasonal viral illness that hospitalizes thousands of babies each year.

23 Mar 2026

New report provides the most detailed picture of preventable child deaths worldwide

An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new estimates released today.

18 Mar 2026

Children develop stronger immunity after repeated infections in nursery

Young children who attend nursery get sick more often than those who don't, but they will go on to have fewer illnesses during early school years, finds a new review of evidence by a group of parent-scientists involving University College London (UCL) researchers.

18 Mar 2026

Protein targeted by cancer drugs may help the body fight influenza

A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX).

18 Mar 2026

Automated system boosts maternal smoking cessation in pediatric care

Researchers at Children's Hospital of Philadelphia (CHOP) found that a new automated tobacco treatment system integrated into routine pediatric care helped drive a 3.9% absolute increase in smoking cessation among mothers – a population-level impact that could translate to tens of thousands of parents quitting each year and protect hundreds of thousands of children from harmful secondhand smoke exposure.

17 Mar 2026

Study uncovers how tuberculosis bacteria fuel themselves during infection

Researchers at The Hospital for Sick Children (SickKids) have uncovered how the bacteria that causes tuberculosis fuels itself during infection, providing new insights into one of the world's deadliest infectious diseases.

17 Mar 2026

Bedfont® Scientific Limited strengthens its position as world leaders in breath analysis with a new board member

Bedfont® Scientific Ltd., a world leader in breath analysis, has been designing and manufacturing medical breath analysis devices for almost 50 years and has seen significant growth over the past decade.

From Bedfont® Scientific Ltd 17 Mar 2026

Investigational oral therapy shows safety and potential benefits in ALS trial

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement and potential clinical benefits.

16 Mar 2026